Proper cell cycle-dependent expression of replicationdependent histones is essential for packaging of DNA into chromatin during replication. We previously showed that cyclin-dependent kinase-9 (CDK9) controls histone H2B monoubiquitination (H2Bub1) to direct the recruitment of specific mRNA 3 0 end processing proteins to replicationdependent histone genes and promote proper pre-mRNA 3 0 end processing. We now show that p53 decreases the expression of the histone-specific transcriptional regulator Nuclear Protein, Ataxia-Telangiectasia Locus (NPAT) by inducing a G1 cell-cycle arrest, thereby affecting E2F-dependent transcription of the NPAT gene. Furthermore, NPAT is essential for histone mRNA 3 0 end processing and recruits CDK9 to replication-dependent histone genes. Reduced NPAT expression following p53 activation or small interfering RNA knockdown decreases CDK9 recruitment and replication-dependent histone gene transcription but increases the polyadenylation of remaining histone mRNAs. Thus, we present evidence that the induction of a G1 cell-cycle arrest (for example, following p53 accumulation) alters histone mRNA 3 0 end processing and uncover the first mechanism of a regulated switch in the mode of pre-mRNA 3 0 end processing during a normal cellular process, which may be altered during tumorigenesis.
Introduction
Histone protein synthesis is regulated both transcriptionally and post-transcriptionally and is essential for the proper packaging of newly synthesized DNA into chromatin during S phase (Marzluff et al., 2008) . Unlike most RNA polymerase II transcribed mRNAs, replication-dependent histone mRNAs are not polyadenylated but instead end in a conserved 3 0 stem-loop structure, which is recognized and cleaved by the stem-loopbinding protein and the U7 snRNP complexes, respectively (Marzluff et al., 2008) . It is surprising that the loss of normal histone pre-mRNA processing can result in the production of polyadenylated mRNAs from the replication-dependent histone genes (Narita et al., 2007; Wagner et al., 2007) . The levels of polyadenylated canonical histone mRNAs are very low in proliferating cells (Narita et al., 2007; Pirngruber et al., 2009b) but may increase during terminal differentiation (Kirsh et al., 1989; Collart et al., 1991) or during tumorigenesis (Zhao et al., 2004; Abba et al., 2005; Martinez et al., 2007) , and opens the possibility that these transcripts may serve an important physiological role. However, the mechanisms regulating the switch from canonical histone pre-mRNA processing to polyadenylation remain elusive.
Nuclear Protein, Ataxia-Telangiectasia Locus (NPAT/ p220) stimulates the transcription of all replicationdependent histone genes during S phase (Gao et al., 2003; Ye et al., 2003) in a phosphorylation-dependent manner (Zhao et al., 1998 (Zhao et al., , 2000 Ma et al., 2000) . NPAT functions, in part, by recruiting coactivator proteins including histone-modifying enzymes (DeRan et al., 2008) . Moreover, NPAT transcription is regulated in a cell cycle-dependent manner by the E2F family of transcription factors (Gao et al., 2003) . However, no role for NPAT in histone mRNA 3 0 end processing has been reported.
Mutation or deletion of the tumor suppressor gene p53 is one of the most common genetic aberrations during tumorigenesis. One of the essential roles in the tumor suppressor function of p53 is the regulation of cell-cycle progression. Most notably, accumulation of the p53 protein can induce a G1 cell-cycle arrest by directly binding and transcriptionally activating the expression of the p21 cyclin-dependent kinase (CDK) inhibitor gene. p21 functions by decreasing cell cycleregulated CDK activity, which in turn decreases the phosphorylation of retinoblastoma protein (RB) family members and ultimately E2F transcriptional activity. Maintaining an intact p21/RB pathway has been shown to be essential for a significant amount of transcriptional repression elicited by p53 (Lohr et al., 2003) . Although p53-induced cell-cycle arrest would be expected to affect replication-dependent histone gene expression, whether this regulation occurs through the p21/CDK/RB/E2F pathway, whether NPAT gene expression is regulated by this pathway and whether these have functional consequences for replication-dependent histone premRNA processing remain unknown.
Recent studies have uncovered a connection between chromatin and RNA processing. For example, the chromodomain protein CHD1 binds H3K4me3 and is essential for proper mRNA splicing (Sims et al., 2007) , whereas the variant histones H2Av and H3.3 control replication-dependent histone pre-mRNA 3 0 end processing in Drosophila (Wagner et al., 2007) . We uncovered a role of CDK9 and specific histone modifications including H2B monoubiquitination (H2Bub1) in controlling replication-dependent histone pre-mRNA 3 0 end processing in mammalian cells (Pirngruber et al., 2009a, b) . In both Drosophila and human cells, interference with chromatin structure resulted in the production of polyadenylated histone mRNAs from the replication-dependent histone genes. However, how these processes are regulated and whether the observed shift in the mode of pre-mRNA 3 0 end processing occurs under normal cellular processes remains unknown. In this study, we identified a reciprocal regulation of replication-dependent histone gene transcription and mRNA polyadenylation in which the induction of a G1 cell-cycle arrest following p53 accumulation resulted in the production of polyadenylated transcripts. This effect was recapitulated by the induction of quiescence following the removal of serum, after treatment with hydroxyurea or after knockdown of cyclin E1. This regulation was further investigated and found to be dependent on p53-induced expression of the CDK inhibitor p21, a decrease in NPAT gene expression caused by increased binding of the E2F4/p130 repressor complex to the NPAT promoter, and decreased recruitment of NPAT, CDK9 and polymerase associated factor-1 (PAF1) to endogenous replication-dependent histone genes.
Results

P53
regulates histone pre-mRNA 3 0 end processing Gene expression microarray studies are typically based on an initial polyT-primed reverse transcription step that specifically labels polyadenylated mRNAs. A number of microarray studies identified changes in the expression of replication-dependent histone genes, thus uncovering potential regulatory pathways controlling histone pre-mRNA 3 0 end processing. One study identified a correlation between replication-dependent histone mRNA polyadenylation and p53 status in head and neck squamous cell carcinomas (Yan et al., 2007) , while another study identified a downregulation in the expression of polyadenylated replication-dependent histone mRNAs in human papilloma virus-positive (HPV þ ) squamous cell carcinoma of the head and neck (Martinez et al., 2007) . As p53 is a primary target of the HPV E6 oncoprotein (zur Hausen and de Villiers, 1994) , it is possible that the changes observed in the second study were also due to regulation of p53 function. Therefore, we tested whether the accumulation of p53 affects replication-dependent histone pre-mRNA 3 0 end processing by treating wild-type (p53 þ / þ ), p53 null (p53À/À) or p21 null (p21À/À) HCT116 cells with Nutlin-3a, which increases endogenous p53 protein levels by blocking the interaction with its negative regulator murine double minute-2 (MDM2). Consistent with the role of p53 and its downstream target gene, the CDK inhibitor p21, in controlling cell-cycle progression, Nutlin-3a treatment increased the fraction of cells in the G1 cell cycle phase (Figure 1a) , decreased RB phosphorylation ( Figure 1b ) and decreased total replication-dependent histone gene expression (HIST1H2BD and HIST1H2AC) in a p53-and p21-dependent manner (Supplementary Figure S1 and Figures 1c and d Figure S2) . In contrast to total replication-dependent histone gene expression, the levels of polyadenylated HIST1H2BD and HIST1H2AC increased following Nutlin-3a treatment (Figures 1c and d, right panel) . Taking the downregulation of total mRNA levels into account, these results reflect approximately 20-and 10-fold increases in the polyadenylated fractions of HIST1H2BD and HIST1H2AC mRNAs, respectively. The p21 dependence was not due to a loss of p53 transcriptional activity, as the induction of the negative feedback regulator MDM2 was maintained in the absence of p21 (Figure 1e ). Furthermore, as expected, owing to a decreased need for new histone protein production in non-proliferating cells, no changes in overall histone protein levels were detected (Supplementary Figure S3 ).
P53 accumulation affects CDK9 and PAF1 recruitment
On the basis of our previous studies (Pirngruber et al., 2009b) , we hypothesized that the effects of p53 accumulation on histone pre-mRNA 3 0 end processing may be due to changes in the recruitment of CDK9 and PAF1, which are both essential for H2B monoubiquitination and maintaining normal histone pre-mRNA 3 0 end processing. We therefore performed chromatin immunoprecipitation (ChIP) analyses using control or Nutlin-3a-treated wild-type HCT116 cells. Consistent with our hypothesis, CDK9 and PAF1 were preferentially localized to the 3 0 end cleavage site (0.5 kb), and their levels at both the transcriptional start site (TSS) and 0.5 kb decreased following Nutlin-3a treatment (Figures 2a and b) . All factors were absent from an unrelated intergenic region close to the trefoil factor-1 (TFF1) gene, which is silent in estrogen receptornegative cell lines including HCT116 (Figure 2 and data not shown).
Decreased NPAT recruitment to the TSS and 0.5 kb following p53 accumulation Given the role for NPAT in controlling replicationdependent histone expression, we also examined its recruitment to two replication-dependent histone genes (HIST1H2BD and HIST1H2AC) following Nutlin-3a treatment. It is surprising that despite its reported role as a site-specific transcriptional cofactor, we detected NPAT at both the TSS and 0.5 kb regions of the histone genes, indicating a potential role in histone pre-mRNA 3 0 end processing (Figure 2c ). Importantly, NPAT recruitment to these genes was decreased at both positions following Nutlin-3a treatment.
Cell cycle and histone mRNA polyadenylation The correlation between p53-induced cell-cycle arrest and the changes in histone mRNA expression and polyadenylation prompted us to perform time course analyses following Nutlin-3a treatment. Total replication-dependent histone mRNA levels already dropped at 8 h after treatment, which preceded an increase in polyadenylated mRNAs (Figure 3a) . The time-dependent decrease in total histone mRNA levels correlated with decreases in NPAT mRNA levels (Figure 3b ) and the fraction of cells in S phase (Figure 3d , Supplementary Figure S4 ). These effects were preceded by an increase in p21 mRNA levels (Figure 3c ), which also preceded an increase in the fraction of cells in G1 phase (Figure 3d ).
Additional protein expression analyses supported that p53 accumulation correlates with the induction of p21 mRNA levels (4 h) and precedes maximal p21 protein levels (8 h), which in turn precede a decrease in NPAT expression and phosphorylation (16 h) and ultimately a dramatic decrease in total NPAT protein levels (24 h) ( Figure 3e ). In contrast, CDK9 and cyclin T1 levels were unaffected by Nutlin-3a treatment. Importantly, and consistent with the role of p21 in controlling E2F and RB activity, the effects of Nutlin-3a on NPAT expression are dependent on both p53 and p21 (Supplementary Figure S5A) .
The induction of cell-cycle arrest results in a decrease in E2F transcriptional activity caused by changes in the complex formation between specific E2F and RB family members and their recruitment to E2F target genes (Takahashi et al., 2000) . In particular, E2F4 and the RB family member p130 are specifically associated with G1 cell-cycle arrest and quiescence (G0) (Vairo et al., 1995) . Therefore, as NPAT is an E2F target gene, we tested whether p53-induced G1 cell-cycle arrest also resulted in an increase in E2F4 and p130 binding to the NPAT gene. Indeed, E2F1, E2F4 and p130 were all detectable on both the NPAT and p107 genes, and the levels of E2F4 and p130 increased following Nutlin-3a treatment ( Figure 3f , Supplementary Figure S5B ). All three proteins were not detectable on the TFF1 gene (Supplementary Figure S5B) .
As NPAT expression was reported to regulate the formation of subnuclear coilin-containing Cajal bodies genotypes were treated as in (a) and analyzed by western blot for RB expression and phosphorylation using an antibody that detects total RB. HSC70 is shown as a loading control. (c-e) Total RNA from HCT1116 cells with the indicated genotypes that were either control (dimethyl sulfoxide) or Nutlin-3a treated were analyzed by random-(left panels) or oligo-dT-primed (right panels) quantitative reverse transcriptase PCR for the expression of total or polyadenylated HIST1H2BD (c), HIST1H2AC (d) and MDM2 (e). Gene expression was normalized to an unregulated gene, RPLP0, and the control condition, and is represented as relative mRNA expression; mean values þ s.d., n ¼ 3.
G1 cell-cycle arrest controls histone mRNA processing J Pirngruber and SA Johnsen (Ye et al., 2003) and ionizing irradiation downregulated NPAT expression and caused a loss of focal nuclear NPAT staining (Su et al., 2004) , we also tested whether p53 accumulation affected NPAT localization and Cajal body integrity. Consistent with the western blot results, the number of NPAT foci per cell dropped dramatically to nearly background levels following Nutlin-3a treatment, whereas Cajal body structure was maintained (Figure 3g, Supplementary Figure S5C) . However, the overall colocalization frequency of NPAT to Cajal bodies was not affected by Nutlin-3a treatment as 79.6 and 80.0% of NPAT foci colocalized with Coilin in the presence or absence of Nutlin-3a, respectively (n ¼ 23). Thus, p53 accumulation specifically affects histone locus body formation by NPAT without affecting overall Cajal body structure.
Increased histone mRNA polyadenylation is a result of G1 cell-cycle arrest To determine whether the effects of Nutlin-3a treatment on histone mRNA polyadenylation were a specific effect of p53 accumulation or a more general consequence of G1 cell-cycle arrest, we induced quiescence in HCT116 cells by serum starvation. As expected, serum starvation substantially increased the G0/G1 cell fraction (Figure 4a ). Similar to Nutlin-3a treatment, serum starvation also increased histone mRNA polyadenylation ( Figure 4b and Supplementary Figure S6A) . Furthermore, we also performed knockdown analyses of the G1/S cyclin E1 (Figure 4c ) and observed decreases in NPAT protein levels ( Figure 4d ) and total replication-dependent histone gene expression, but significant increases in polyadenylated histone gene transcripts G1 cell-cycle arrest controls histone mRNA processing J Pirngruber and SA Johnsen ( Figure 4e and Supplementary Figure 6B ). These effects were also independent of p53 status as the knockdown of cyclin E1 in p53 null HCT116 cells also resulted in similar effects on histone gene expression and premRNA 3 0 end processing as seen in wild-type HCT116 cells (Supplementary Figure S7) .
The anti-neoplastic drug hydroxyurea (HU) inhibits DNA replication thereby causing an arrest in G1 or early S phase of the cell cycle and eventually leads to the formation of double-strand breaks and the induction of a DNA damage response (Rappold et al., 2001; Saintigny et al., 2001) . Therefore, we also tested whether HU treatment may also affect replication-dependent histone mRNA 3 0 end processing. Indeed, HU treatment for 48 h reciprocally decreased total histone mRNA levels and increased polyadenylated mRNA levels irrespective of p53 status (Figure 4f and Supplementary Figure 6C and data not shown).
NPAT regulates histone pre-mRNA 3 0 end processing The presence of NPAT at the TSS and 3 0 end processing sites on histone genes, combined with the inverse correlation between NPAT and polyadenylated histone mRNA expression, suggested that NPAT may function to regulate both replication-dependent histone transcription and 3 0 end processing. Thus, we transfected HCT116 cells with two individual small interfering RNAs (siRNAs) against NPAT and performed gene expression analyses. Consistent with previous reports, NPAT knockdown (Figure 5c , Supplementary Figures S8C and D) resulted in a decrease in total histone mRNA levels (Figures 5a and b , Supplementary Figures S8A and B) . In contrast, and similar to Nutlin-3a treatment or cyclin E1 knockdown, NPAT knockdown resulted in a dramatic increase in the levels of polyadenylated histone mRNAs (Figures 5a and b Figure 1c at the indicated times following Nutlin-3a treatment. The expression of NPAT (b) and p21 (c) mRNA was analyzed by random-primed quantitative reverse transcriptase PCR as performed for total HIST1H2BD in (a). Gene expression levels were normalized and expressed as in Figure 1 ; mean values þ s.d., n ¼ 2. (d) Combined propidium iodide/5-bromodeoxyuridine staining (left panel) or propidium iodide alone (right panel) were performed as in Figure 1a to determine the kinetic induction of cell-cycle arrest following Nutlin-3a treatment. The percentage of cells in the S and G1 phases is indicated. (e) Western blot analysis was performed on protein samples prepared in parallel to the samples in (a-d) using the indicated antibodies. HSC70 is shown as a loading control. (f) E2F4 and p130 binding to the NPAT promoter increases following Nutlin-3a treatment. E2F1, E2F4 and p130 recruitment to the NPAT gene was investigated by ChIP analysis. qChIP values were normalized as in Figure 2 ; mean values þ s.d., n ¼ 3. The experimental background is shown as a dotted line. (g) Nutlin-3a treatment decreases the number of NPAT foci without affecting the number or intensity of Cajal bodies. HCT116 cells were treated with Nutlin-3a for 24 h and analyzed by confocal immunofluorescence microscopy using specific antibodies against NPAT (red) or Coilin (green). 4,6-Diamidino-2-phenylindole staining (blue) indicates the nuclei of individual cells. The white line in the bottom right corner indicates a size of 10 mm. A full colour version of this figure is available at the Oncogene journal online.
G1 cell-cycle arrest controls histone mRNA processing J Pirngruber and SA Johnsen Figures S8A and B) similar to that observed following CDK9 knockdown (Supplementary Figure S8E ) (Pirngruber et al., 2009b) .
NPAT helps recruit CDK9 to histone genes Given the similarities between the effects of Nutlin-3a treatment and NPAT knockdown on histone premRNA 3 0 end processing and the role of CDK9 in suppressing histone mRNA polyadenylation, we tested whether NPAT and the CDK9/cyclin T1 complex interact in vitro using glutathione S-transferase (GST) pull-down analyses. On the basis of the presence of an RXL cyclin-binding motif at positions 1062-1066 of the NPAT protein and a previous report indicating that another RXL domain directly interacts with a CDK9 complex (Simone et al., 2002) , we tested whether this region (amino acids 801-1100) of NPAT may also interact with the CDK9/cyclin T1 complex. Indeed, as shown in Figure 5d , the GST-NPAT 801À1100 fusion protein, but not GST alone, was capable of pulling down both cyclin T1 and CDK9.
To verify this interaction in vivo, we performed coimmunoprecipitation analyses with antibodies against CDK9 and NPAT. Indeed, immunoprecipitation of CDK9 resulted in a specific co-immunoprecipitation of NPAT (Figure 5e ). Similarly, immunoprecipitation of NPAT also co-immunoprecipitated cyclin T1 and CDK9 as detected with two separate CDK9 antibodies.
We further tested whether the NPAT-CDK9 interaction is of functional consequence by performing ChIP analyses on two histone genes and a control locus following transfection with either control or NPAT siRNAs. As observed following Nutlin-3a treatment, NPAT knockdown resulted in decreases in both CDK9 and PAF1 recruitment (Figures 6a and b) . These effects were most pronounced at 0.5 kb, consistent with the roles of NPAT, CDK9 and PAF1 in controlling 3 0 end processing. The effectiveness of the NPAT knockdown was verified by ChIP against NPAT (Figure 6c ). These effects were also specific for NPAT knockdown, as the transfection of two different control siRNAs did not appreciably affect CDK9, PAF1 or NPAT recruitment compared with mock-transfected cells ( Supplementary  Figures S9A-C) . Figure 4 Accumulation of polyadenylated replication-dependent histone mRNAs is induced following a G1/G0 cell-cycle arrest. (a) HCT116 cells were grown in serum-free medium for 24 h and cell-cycle distribution was analyzed by propidium iodide-based flow cytometry as in Figure 1a. (b) Serum starvation downregulates total HIST1H2BD but increases mRNA polyadenylation. Gene expression levels were normalized and expressed as in Figure 1 ; mean values þ s.d., n ¼ 2. (c-e) Cyclin E1 knockdown similarly decreases NPAT and replication-dependent histone gene expression and induces histone mRNA polyadenylation. (c) The effectiveness of cyclin E1 knockdown was assessed by randomprimed quantitative reverse transcriptase PCR in HCT116 cells at 52 h after transfection with control or cyclin E1 siRNAs. (d) Western blot analysis was performed on protein samples prepared in parallel to the samples in (c, e) using NPAT or HSC70 antibodies. HSC70 is shown as a loading control. (e) The expression of total and polyadenylated HIST1H2BD mRNA was assessed as in Figure 1 using the same RNA samples as in (c). Gene expression levels were normalized and expressed as in Figure 1 ; mean values þ s.d., n ¼ 2. (f) The expression of total and polyadenylated HIST1H2BD was analyzed as in Figure 1c after treatment with 2 mM hydroxyurea for 48 h. Gene expression levels were normalized and expressed as in Figure 1 ; mean values þ s.d., n ¼ 2.
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Discussion
The induction of p53-dependent cell-cycle arrest has an important role in the control of cellular proliferation and may help protect cells against the effects of certain chemotherapeutic agents (Carvajal et al., 2005; Kranz and Dobbelstein, 2006) . The induction of polyadenylated mRNAs produced from replication-dependent histone genes following p53-induced G1 cell-cycle arrest may be significant as the polyadenylated histone transcripts have a longer half-life than the normally processed transcripts from the same genes (Kirsh et al., 1989) and are translated in a cell cycle-independent manner. This may be important, for example, in quiescent or terminally differentiated cells in which the, albeit lower, levels of polyadenylated histone mRNAs (compared with non-polyadenylated expressed during S phase) would serve to maintain proper DNA packaging and chromatin structure in the absence of DNA replication. Although the existence of polyadenylated canonical histone transcripts produced from replication-dependent histone genes has been previously reported in mammalian cells (Kirsh et al., 1989; Narita et al., 2007; Pirngruber et al., 2009b) , the mechanisms that control when and how these transcripts are produced remained a mystery. Our data provide the first evidence that the induction of a G1 cell-cycle arrest following p53 accumulation, serum withdrawal, cyclin E1 knockdown or HU treatment leads to an increase in the production of polyadenylated histone transcripts produced from canonical replication-dependent histone genes. We have shown that in the case of Nutlin-3a treatment this regulation is dependent on both p53 and its downstream target p21. Our results suggest a timedependent model in which p53 induction leads to an increase in p21 gene expression. This in turn causes an accumulation of cells in the G1 phase and leads to a decrease in E2F transcriptional activity, which ultimately decreases NPAT gene expression. We have shown that NPAT forms a complex with CDK9 and cyclin T1 and thereby likely functions to modulate chromatin modifications through the recruitment of the RNA polymerase II-associated PAF complex. On the basis of these data and the model we previously described (Pirngruber et al., 2009a, b) , we propose that NPAT gene expression during normal cell-cycle progression leads to the recruitment of the P-TEFb complex (CDK9/cyclin T1; Figure 6d ), thereby facilitating PAF1 recruitment and histone H2B monoubiquitination (not shown). This in turn increases both the transcription and efficiency of canonical histone mRNA 3 0 end processing. In contrast, during G1/G0 cell-cycle arrest, NPAT expression is decreased and P-TEFb is less efficiently recruited (Figure 6e ). This results in decreased overall levels of replication-dependent histone gene transcription but an increase in cell cycle-independent 3 0 end processing (polyadenylation). The correct packaging of DNA into chromatin is essential for maintaining genomic integrity and structure during normal cell-cycle progression. To maintain this structure, cells use a number of intricate mechanisms to Figure 1 . (c) The effectiveness of NPAT knockdown was assessed by random-primed quantitative reverse transcriptase PCR using the same RNA samples as in (a). Gene expression levels were normalized and expressed as in Figure 1 ; mean values þ s.d., n ¼ 2.
(d, e) Complex formation between NPAT and CDK9/cyclin T1. (d) in vitro GST pull-down analysis was performed using in vitro transcribed and translated P-TEFb (CDK9/CyclinT1) as a bait for bacterially expressed and purified GST or GST-NPAT 801À1100 , which contains the RXL cyclin-binding motif. (e) HCT116 cell lysates were immunoprecipitated with nonspecific IgG or antibodies against endogenous NPAT and CDK9. Endogenous coimmunoprecipitated proteins were revealed by western blot analysis against CDK9, cyclin T1 and NPAT. G1 cell-cycle arrest controls histone mRNA processing J Pirngruber and SA Johnsen alternative 3 0 end-processed (polyadenylated) mRNAs produced from normally replication-dependent histone genes may be a previously unrecognized, but relatively simple, mechanism of producing canonical histones outside the S phase. This extra source of S phase-independent histones may be advantageous for quiescent, terminally differentiated cells or tumor cells. Consistent with a potential positive role of polyadenylated histone mRNAs during tumorigenesis, the overexpression of a transgene that produces a polyadenylated mRNA encoding a canonical core histone was sufficient to increase epidermal growth factor-induced cellular proliferation (Choi et al., 2005) . Furthermore, the expression of polyadenylated canonical histone mRNAs may be important for cells experiencing DNA damage. The polyubiquitination and exchange of core histones following DNA damage is essential for the cellular DNA damage response (Wang et al., 2006; Huen et al., 2007; Mailand et al., 2007) . Therefore, newly synthesized histone proteins (that is, from the polyadenylated histone mRNAs) may help maintain proper chromatin structure subsequent to DNA repair. In this way, the accumulation of polyadenylated histone transcripts may be an additional way in which p53 accumulation helps maintain genomic integrity. Future studies, which specifically address the role of these transcripts in the protective effects of p53 accumulation before DNA damage and the expression of these transcripts in primary tumor samples, will further clarify their physiological importance.
Materials and methods
Cell culture, transfection and western blot analysis HCT116 cells were grown in McCoy's medium containing 10% fetal bovine serum and 1 Â penicillin/streptomycin and treated with Nutlin-3a (Sigma, Munich, Germany) as indicated. Transfection of siRNAs (listed in Supplementary Table S1) was performed using Lipofectamine RNAiMAX (Invitrogen, Heidelberg, Germany) according to the manufacturer's instructions. Western blot analysis was performed using the antibodies listed in Supplementary Table S2 .
Co-immunoprecipitation and GST pull-down analyses Co-immunoprecipitation analysis was performed as previously described (Shin et al., 2007) using the indicated antibodies as listed in Supplementary Table S2 . GST pull-down analyses were performed as previously described (Johnsen et al., 2002) .
ChIP and gene expression analysis ChIP analyses using the antibodies and dilutions listed in Supplementary Table S2 were performed as previously described (Pirngruber et al., 2009b) . RNA was harvested with Qiazol (Qiagen, Hilden, Germany) according to the manufacturer's instructions and reverse transcribed using either oligo-dT or random nonamer primers as indicated in the respective figure legends. DNA samples (ChIP or cDNA) were analyzed by SYBR Green-based real-time PCR using a relative standard curve and a PCR buffer (75 mM Tris-HCl (pH 8.8), 20 mM (NH 4 ) 2 SO 4 , 0.01% Tween-20) containing 3 mM MgCl 2 , 200 mM dNTPs, 0.5 U per reaction Taq DNA polymerase (PrimeTech, Minsk, Belarus), 0.25% Triton X-100, 1:80 000 SYBR Green I (Roche, Mannheim, Germany), 300 mM trehalose and 300 nM primers. Primers used are listed in Supplementary Tables S3 and S4 . Experimental background was determined by performing a control ChIP with a nonspecific IgG. The average of the background signals for all primer pairs were similar and are graphically represented by the dotted line. All quantitative reverse transcriptase PCRs were normalized to RPLP0 before additional normalization and statistical analyses.
Immunofluorescence microscopy Indirect immunofluorescence stainings were performed as previously described (Lemm et al., 2006) using the antibodies as listed in Supplementary Table S2 . Fluorescent-labeled samples were visualized under identical conditions for control and Nutlin-3a-treated cells using a Zeiss LSM Meta 510 confocal microscope (Oberkochen, Germany).
Flow cytometry
Cells were prepared for propidium iodide-based flow cytometric cell cycle analysis as described (Kranz and Dobbelstein, 2006) and analyzed using a Guava EasyCyte plus (Guava Technologies, Hayward, CA, USA), and data were analyzed and graphically displayed using ModFit (Verity Software House, Topsham, ME, USA). 5-Bromodeoxyuridine analyses were performed essentially as described (Kranz et al., 2008) using the antibodies listed in Supplementary Table S2 . Annexin V apoptosis assays were performed using the Guava Nexin Reagent (Guava Technologies) according to the manufacturer's instructions.
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The authors declare no conflict of interest. Figure 6 NPAT knockdown mimics p53-induced G1 cell-cycle arrest and is required for optimal recruitment of CDK9 and PAF1. Protein recruitment to a negative-control locus (TFF1) and the TSS and 0.5 kb regions of HIST1H2BD and HIST1H2AC was investigated by ChIP analysis as in Figure 2 using antibodies against CDK9 (a), PAF1 (b) and NPAT as a knockdown control (c). qChIP values were normalized as in Figure 2 ; mean values þ s.d., n ¼ 3. The experimental background (control IgG) is shown as a dotted line. (d, e) Proposed model of NPAT/P-TEFb interactions in controlling the mode of replication-dependent histone mRNA transcription and 3 0 end processing. (d) During normal cell-cycle progression, NPAT is expressed in an E2F-dependent manner and recruited to histone genes through other factors such as Oct1 and is activated through phosphorylation by CDK2/cyclin E1. NPAT binding increases P-TEFb (CDK9/cyclin T1) recruitment, thereby increasing histone gene transcription and canonical 3 0 end processing through increased RNA polymerase II CTD phosphorylation and subsequent recruitment of PAF1 and histone H2B monoubiquitination. (e) Owing to the decreased expression of NPAT during G1/G0 cell-cycle arrest, less P-TEFb is recruited to the replication-dependent histone genes, thereby decreasing overall transcription and increasing the frequency of histone mRNA polyadenylation.
